News headlines about Markel (NYSE:MKL) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Markel earned a daily sentiment score of 0.22 on Accern’s scale. Accern also gave news coverage about the insurance provider an impact score of 45.8275848712581 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the news articles that may have impacted Accern’s rankings:
Markel (NYSE MKL) traded down $1.16 during trading on Thursday, hitting $1,105.17. 60,000 shares of the company’s stock traded hands, compared to its average volume of 40,509. Markel has a 1 year low of $612.00 and a 1 year high of $1,157.30. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.55 and a current ratio of 0.55. The company has a market cap of $15,370.00, a PE ratio of 246.14 and a beta of 1.04.
Several equities analysts have commented on MKL shares. SunTrust Banks reissued a “hold” rating and set a $1,100.00 target price on shares of Markel in a research report on Friday, October 27th. Royal Bank of Canada reissued a “hold” rating and set a $1,050.00 target price on shares of Markel in a research report on Tuesday, October 3rd. Zacks Investment Research cut shares of Markel from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, Boenning Scattergood reissued a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Markel presently has a consensus rating of “Hold” and a consensus price target of $1,113.25.
In related news, Vice Chairman Steven A. Markel sold 200 shares of Markel stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $1,067.57, for a total value of $213,514.00. Following the sale, the insider now owns 109,220 shares of the company’s stock, valued at approximately $116,599,995.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Alan I. Kirshner sold 100 shares of Markel stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $1,133.50, for a total transaction of $113,350.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 2,307 shares of company stock worth $2,535,956. Insiders own 2.53% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/11/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-markel-mkl-share-price.html.
Markel Company Profile
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.